Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E for Retinopathy of Prematurity in Preterm Infants
NCT03274596Completed
- Sponsor
- National Institute of Perinatology
- Start
- Mar 2013
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Randomised, double-blind trial in retinopathy of prematurity (ROP) comparing Vitamin E with Placebo (2 arms). Primary endpoint: Incidence of retinopathy of prematurity at 28 days. Started Mar 2013; status: completed.
02
Drugs
vitamin e
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT03274596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274596.